The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette FDA Compliance for Peptide Therapy and BPC 157 Holt Law BPC 157 10mg TB 500 10mg Blend NewBioRx